Nektar Therapeutics

Nektar Therapeutics

Price & Volume

Stats

See more
52W Range
$33.40-$109
Market Cap
$1.4B
Shares Short
6M

Financials

See more
Revenue (12 Mos)
$54.5M
Revenue Growth (YoY)
-9.3%
Gross Profit (12 Mos)
$54.5M
Diluted EPS
-$18.96

About

CEO
Mr. Howard W. Robin
CFO
Ms. Linda M. Rubinstein M.A.
Address
455 Mission Bay Boulevard South, San Francisco, CA, United States, 94158
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
63